NPTX1

NPTX1 is a secreted, nervous-system-enriched pentraxin that operates as both an extracellular signaling modulator and an intracellular regulator of cell growth and differentiation (PMID:8884281). During neural induction it binds the Nodal co-receptor TDGF1 to dampen Nodal and BMP signaling, and its gain or loss can respectively initiate or reduce neural lineage commitment (PMID:24529709). The functional protein assembles into high-molecular-weight oligomeric complexes; disease-associated missense variants (p.E327G, p.G389R) destabilize the monomer interface, abolish secretion, and trigger ATF6-mediated ER stress and cytotoxicity, linking NPTX1 misfolding to a neurological disorder (PMID:34788392). In neurons NPTX1 shapes circuit excitability and synaptic function: it facilitates Kv7.2-mediated inhibition in dentate gyrus engram ensembles to suppress hyperexcitability and promote memory precision [PMID:bio_10.1101_2025.05.19.654996], and its loss in spinal dorsal horn neurons enhances AMPAR (GluA1) membrane trafficking to drive central sensitization and neuropathic pain (PMID:41457187). NPTX1 abundance is tightly controlled post-transcriptionally and post-translationally — its mRNA is stabilized by RBM10 (PMID:35836482), while the E3 ligase MKRN3 and the chaperone SIGMAR1 each direct it to ubiquitin-proteasome degradation (PMID:29156706, PMID:41457187). In non-neural contexts it acts as a growth and migration modulator, stabilizing β-catenin downstream of MEK signaling (PMID:40240141), promoting integrin/FAK-mediated migration and invasion (PMID:31043800), and restraining proliferation through cyclin A2/CDK2-dependent Rb-E2F control (PMID:29345391).

1. 1996 Medium

   Established the molecular identity of NPTX1 as a secreted, nervous-system-restricted pentraxin, providing the foundation for all subsequent functional work.

   Evidence cDNA cloning, genomic sequencing, Northern blot, and chromosomal mapping to 17q25

   PMID:8884281

   Open questions at the time

   • Synaptic uptake function inferred from prior rat work, not directly re-demonstrated
   • No structure of the secreted protein
   • Binding partners not yet identified
2. 2014 Medium

   Defined a developmental signaling role by showing NPTX1 binds the Nodal co-receptor TDGF1 to suppress Nodal/BMP signaling and gate neural fate.

   Evidence Binding assay plus gain/loss-of-function in human pluripotent stem cells

   PMID:24529709

   Open questions at the time

   • Stoichiometry and structural basis of NPTX1–TDGF1 binding unknown
   • Whether oligomerization is required for TDGF1 inhibition not tested
3. 2017 Medium

   Identified post-translational control of NPTX1 by showing MKRN3 E3 ligase polyubiquitinates it to suppress its activity during pubertal timing.

   Evidence Co-IP, ubiquitination assay, and Ring-finger domain deletion in mouse hypothalamus

   PMID:29156706

   Open questions at the time

   • Ubiquitin chain topology and degradation kinetics not defined
   • Downstream NPTX1 effectors in puberty not identified
4. 2018 Medium

   Connected NPTX1 to cell-cycle restraint, showing it suppresses proliferation via cyclin A2/CDK2 and Rb-E2F signaling.

   Evidence Overexpression, cell cycle assays, and mouse xenografts in colon cancer cells

   PMID:29345391

   Open questions at the time

   • Direct molecular link between secreted NPTX1 and intracellular cyclin A2/CDK2 unresolved
   • How a secreted protein modulates the cell cycle mechanistically unclear
5. 2019 Medium

   Extended NPTX1's non-neural roles to migration, placing it in the integrin/FAK axis as a driver of invasion in gastric cancer.

   Evidence siRNA knockdown with adhesion, transwell, and pathway Western blots

   PMID:31043800

   Open questions at the time

   • Direct receptor mediating integrin effects not identified
   • Apparent contradiction with proliferation-suppressing role across cancer types unexplained
6. 2022 High

   Revealed that NPTX1 function depends on high-molecular-weight oligomer assembly and that disease missense variants cause loss of secretion plus ATF6 ER stress.

   Evidence COS7 overexpression, ATF6 reporter, Co-IP/MS, secretion assay, and in silico modelling of two variants

   PMID:34788392

   Open questions at the time

   • Cryo-EM/crystal structure of the oligomer absent
   • Whether ER stress drives neurodegeneration in vivo not tested
7. 2022 Medium

   Showed NPTX1 abundance is set transcriptionally upstream by RBM10-mediated mRNA stabilization.

   Evidence RIP and actinomycin D chase in pancreatic cancer cells

   PMID:35836482

   Open questions at the time

   • RBM10 binding site on NPTX1 mRNA not mapped
   • Relevance to neuronal NPTX1 regulation untested
8. 2023 Medium

   Linked NPTX1 to synaptic compartment integrity and disease, showing it is dysregulated in Parkinson's hippocampal synaptosomes and shapes synapse morphology.

   Evidence Synaptosomal proteomics and gain/loss-of-function in primary hippocampal neurons

   PMID:37515330

   Open questions at the time

   • Causal direction between NPTX1 dysregulation and Parkinson's pathology not established
   • Synaptic partners not molecularly defined
9. 2025 Medium

   Defined NPTX1's neuronal output mechanisms: facilitating Kv7.2 inhibition to control engram excitability and memory, and restraining AMPAR trafficking to limit neuropathic pain, with SIGMAR1-driven degradation as upstream control.

   Evidence Engram-specific manipulation, chemogenetics, Kv7.2 pharmacology, AAV overexpression, Co-IP/MS, and behavioral assays in mice (one finding a preprint)

   PMID:41457187 PMID:bio_10.1101_2025.05.19.654996

   Open questions at the time

   • Whether secreted versus intracellular NPTX1 mediates Kv7.2 and AMPAR effects unclear
   • Engram-circuit finding is a preprint not yet peer-reviewed
   • Sex specificity of pain phenotype not generalized
10. 2025 Medium

    Established NPTX1 as a β-catenin stabilizer acting downstream of MEK signaling, defining a non-transcriptional route to CTNNB1 regulation.

    Evidence iPSC genetic models with MEK inhibition and NPTX1 manipulation tracking β-catenin protein

    PMID:40240141

    Open questions at the time

    • Molecular mechanism by which NPTX1 stabilizes β-catenin not resolved
    • Whether oligomerization or secretion is required not tested

• How a single secreted pentraxin reconciles its extracellular ligand-binding roles (TDGF1) with intracellular outputs (β-catenin, cyclin A2/CDK2, Kv7.2, AMPAR) remains the central unresolved question.
• No unifying receptor or transmembrane partner identified
• Structural basis of oligomer-dependent function undetermined
• Context-dependent opposite effects on proliferation across tissues unexplained